Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.

More than two billion people worldwide live with overweight or obesity, conditions closely linked to an array of health ...

Nina King says that Ozempic's rise could shift beauty standards away from thinness as it becomes more accessible.

The explosive rise of GLP-1 drugs like Ozempic has brought an accompanying challenge: logistics too knotty for a single ...

Weight loss tops many folks’ list of New Years resolutions, and lots of people are turning to cutting-edge weight-los ...

The FDA has approved Wegovy to reduce heart ... for Ozempic and Wegovy include possible thyroid tumors, including cancer; pancreatitis, vision changes, low blood sugar, kidney failure, gallbladder ...

Drugs like Ozempic could justify a deal. Hershey ‘now faces long-term headwinds from the expansion of GLP-1 drugs and heightened scrutiny on unhealthy food in the U.S.,’ TD Cowen says ...

In 1987, fewer than one in five American adults were obese, and by 1999, obesity was responsible for more than 300,000 excess ...

GLP-1s such as Ozempic are only available through the program to address certain chronic ailments, such as diabetes or heart disease. That could change under a draft rule the Biden administration ...

Ozempic (semaglutide) has potential interactions with other drugs and some supplements. For example, Ozempic can interact with oral medications and some diabetes medications, including insulin ...